Khayat, M.T.; Abbas, H.A.; Ibrahim, T.S.; Elbaramawi, S.S.; Khayyat, A.N.; Alharbi, M.; Hegazy, W.A.H.; Yehia, F.A.-z.A.
Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems. Biomedicines 2023, 11, 1442.
https://doi.org/10.3390/biomedicines11051442
AMA Style
Khayat MT, Abbas HA, Ibrahim TS, Elbaramawi SS, Khayyat AN, Alharbi M, Hegazy WAH, Yehia FA-zA.
Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems. Biomedicines. 2023; 11(5):1442.
https://doi.org/10.3390/biomedicines11051442
Chicago/Turabian Style
Khayat, Maan T., Hisham A. Abbas, Tarek S. Ibrahim, Samar S. Elbaramawi, Ahdab N. Khayyat, Majed Alharbi, Wael A. H. Hegazy, and Fatma Al-zahraa A. Yehia.
2023. "Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems" Biomedicines 11, no. 5: 1442.
https://doi.org/10.3390/biomedicines11051442
APA Style
Khayat, M. T., Abbas, H. A., Ibrahim, T. S., Elbaramawi, S. S., Khayyat, A. N., Alharbi, M., Hegazy, W. A. H., & Yehia, F. A.-z. A.
(2023). Synergistic Benefits: Exploring the Anti-Virulence Effects of Metformin/Vildagliptin Antidiabetic Combination against Pseudomonas aeruginosa via Controlling Quorum Sensing Systems. Biomedicines, 11(5), 1442.
https://doi.org/10.3390/biomedicines11051442
